CPT® Code 80174

Deleted

1. Indications

The imipramine level test (CPT® Code 80174) is indicated for several specific conditions and symptoms, which include:

• Depression - Imipramine is commonly prescribed to manage symptoms of depression, helping to improve mood and emotional well-being.
• Anxiety/Panic Disorders - The medication is also effective in treating anxiety and panic disorders, providing relief from excessive worry and panic attacks.
• Neuropathic Pain - Imipramine can be used to alleviate chronic pain resulting from nerve damage or dysfunction.
• Attention Deficit-Hyperactivity Disorder (ADHD) - The drug may be prescribed to help manage symptoms associated with ADHD, improving focus and attention.
• Bulimia - Imipramine is sometimes utilized in the treatment of bulimia, aiding in the management of eating disorders.
• Enuresis (Nighttime Bedwetting) - The medication can be prescribed for children experiencing nighttime bedwetting, helping to reduce occurrences.
• Recurring Daytime Sleep Disorders - Imipramine may assist in managing sleep disorders that occur during the day, promoting better sleep patterns.

2. Procedure

The procedure for measuring imipramine levels involves several key steps, which are outlined as follows:

• Step 1: Venipuncture - A qualified healthcare professional performs a venipuncture to obtain a blood sample from the patient. This involves inserting a needle into a vein, typically in the arm, to draw blood. The procedure is performed using sterile techniques to minimize the risk of infection and ensure patient safety.
• Step 2: Serum Preparation - Once the blood sample is collected, it is processed to separate the serum from the cellular components. This is typically done by allowing the blood to clot and then centrifuging it, which separates the liquid serum from the solid elements of the blood.
• Step 3: Testing - The prepared serum is then subjected to analysis using liquid chromatography-tandem mass spectrometry (LC-MS/MS). This advanced testing method allows for the precise quantification of imipramine levels in the serum, providing accurate results that are essential for monitoring the patient's therapeutic drug levels.

3. Post-Procedure

After the imipramine level test is completed, patients may be advised to resume their normal activities. There are generally no specific post-procedure care requirements, as the venipuncture site may be bandaged to prevent bleeding. Patients should be informed about potential minor side effects from the blood draw, such as bruising or discomfort at the puncture site. The results of the test will be analyzed and reported to the prescribing physician, who will interpret the findings in the context of the patient's treatment plan and make any necessary adjustments to medication dosages based on the imipramine levels measured.